Patent · US Active

Methods for crystallizing ERK2 polypeptides

US7722718B2 · kind B2 · utility

0Cited by
0References
5Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 17, 2007
Grant dateMay 25, 2010
Priority date
Expiry dateOct 17, 2027

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2299/00
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present invention relates to crystals of the ERK2 polypeptide and complexes thereof which are useful, inter alia, for structure assisted drug design.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.